Follow Us

New Product for Facial Redness

The FDA has approved a new product that is the first topical treatment specifically indicated for persistent facial redness that is seen in many patients with rosacea. The topical treatment works by constricting the dilated blood vessels and lasts up to 12 hours.

About the Author
Is an Ivy-League trained physician and surgeon who is a board-certified Dermatologist & Mohs' Surgeon. Aside from having training in Internal Medicine and Dermatology, Dr. Bader completed a fully accredited fellowship in Cosmetic Surgery under the auspices of the American Academy of Cosmetic Surgery. He moved to South Florida in June 1999. Shortly thereafter, he formed R.S.B. Dermatology in Deerfield Beach, FL.